Inter- and intra-observer agreement in ultrasound diagnosis of steatotic liver disease: implications for screening in resource-limited settings
Steatotic liver disease (SLD), which is associated with increased risk of cancer-related mortality, needs timely and cost-effective detection. Although liver biopsy remains the diagnostic gold standard, its invasiveness and high-cost limit widespread use. Ultrasound is a practical and affordable alternative. We evaluated inter- and intra-observer agreement for ultrasound-based diagnosis of SLD using images from the Chile Biliary Longitudinal Study (Chile BiLS), a cohort of women with gallstones. These women have a high burden of obesity and related metabolic disorders, putting them at higher risk for SLD. A radiologist (observer 1) reviewed a randomly selected subset of 425 baseline images and compared them with the original readings from Chile BiLS radiology technicians. To assess intra-observer reproducibility, observer 1 reanalyzed 34 blinded duplicates, and two Chile BiLS radiology technicians (observers 2 and 3) independently reviewed these images. Observer 2 then re-reviewed the 34 images to assess intra-observer agreement. Agreement was analyzed using kappa and percent agreement. Observer 1 had slight inter-observer agreement (kappa: 0.12; 95% CI 0.08-0.15, p < 0.001; percent agreement: 41.0%), while observers 2 and 3 showed fair agreement (kappa: 0.29: 95% CI 0.11-0.58, p < 0.05; percent agreement: 64.7% and kappa: 0.32: 95% CI 0.06-0.58, p < 0.05; percent agreement: 63.6%, respectively). Intra-observer agreement was moderate for observer 1 (kappa: 0.45; 95% CI 0.08-0.82, p < 0.05; percent agreement: 81.3%), and substantial for observer 2 (kappa: 0.64; 95% CI 0.37-0.90, p < 0.001; percent agreement: 81.8%). Our findings highlight variability in ultrasound interpretation, underscoring the necessity of inter- and intra-observer comparisons for optimal diagnosis and quality control to enhance diagnostic consistency in high-risk populations.
Authors
- David Wynne (ORCID: https://orcid.org/0000-0001-8881-986X)
- Ilona Argirion (ORCID: https://orcid.org/0000-0002-4925-5296)
- Ruth M. Pfeiffer (ORCID: https://orcid.org/0000-0001-7791-2698)
- Paz Cook
- María Spencer-Sandino (ORCID: https://orcid.org/0009-0002-3995-9297)
- Allan Hildesheim (ORCID: https://orcid.org/0000-0003-0257-2363)
- Vanessa Van De Wyngard
- Noldy Mardones
- Jill Koshiol (ORCID: https://orcid.org/0000-0002-3832-6204)
- Catterina Ferreccio (ORCID: https://orcid.org/0000-0001-6331-5534)
- Maya Balakrishnan (ORCID: https://orcid.org/0000-0002-5196-7284)
Institutions
- University of North Carolina at Chapel Hill (US)
- Michael E. DeBakey VA Medical Center (US)
- Pontificia Universidad Católica de Chile (CL)
- Baylor College of Medicine (US)
- Georgetown University (US)
- Ben Taub Hospital (US)
- Instituto de Salud Pública de Chile (CL)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- Hospital Doctor Hernán Henríquez Aravena (CL)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1038/s41598-025-07862-1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universidad de La Frontera